Understand the source comparison
Real Peptides TB-4 vs Competitors Quality: Research-Grade Comparison
The table below compares Real Peptides TB-4 against typical competitor offerings across critical quality metrics. Data reflects industry standards and third-party verification protocols. Purity Verification Independent HPLC per batch, ≥98% confirmed Manufactur
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares Real Peptides TB-4 against typical competitor offerings across critical quality metrics. Data reflects industry standards and third-party verification protocols.
- Purity Verification
- Independent HPLC per batch, ≥98% confirmed
- Manufacturer CoA only, claimed 95–98%
- No post-synthesis testing, 90–95% typical
- Real Peptides' per-batch HPLC eliminates the 4–12% purity variance documented in untested peptides. Critical for reproducible experimental outcomes
- Endotoxin Testing
- LAL assay per batch, <1 EU/mg guaranteed
- Occasional testing, 2–5 EU/mg range
- Not tested, 5–15 EU/mg typical
- Endotoxin above 5 EU/mg activates immune pathways independent of peptide action. Confounds tissue repair and inflammation studies
- Amino Acid Sequencing
- Full 43-residue confirmation per batch
- Initial product development only
- Not performed
- Structural isomers (wrong amino acid order) pass purity tests but show reduced activity. Sequencing is the only way to detect this
- Batch Size
- ≤500 vials, allows real-time synthesis adjustment
- 2,000–5,000 vials, statistical sampling only
- 10,000+ vials, no per-batch verification
- Small batches allow coupling step correction during synthesis. Large-scale runs cannot halt mid-production to fix errors
- Lyophilization Quality
- Pharmaceutical-grade, <1% residual moisture
- Standard industrial, 2–3% moisture
- Budget equipment, 4–6% moisture
- Residual moisture >3% accelerates peptide bond hydrolysis during storage. Causes 2–6% purity loss over 12 months even at -20°C
- Reconstitution Stability
- ≥95% purity maintained 28 days at 2–8°C
- 90–93% purity at 28 days
- Visible precipitation within 14 days common
- Degraded peptides form aggregates post-reconstitution that reduce bioavailability and cloud solutions. Indicator of poor synthesis
- Published Test Data
- HPLC chromatogram, mass spec, endotoxin results per batch
- Generic CoA, no batch-specific data
- No testing documentation provided
- Batch-specific chromatograms prove the exact vial shipped was tested. Generic CoAs cannot verify individual product quality